Columvi Approved for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Columvi is a CD20xCD3 T-cell engaging bispecific antibody designed with a novel 2:1 structural format.
Diagnosis & Disease Information
Epcoritamab May Induce Durable Complete Responses in LBCL
Researchers sought to determine whether epcoritamab would be effective in patients with LBCL.
Axi-Cel Shows Superior Overall Survival Data vs Standard of Care in LBCL
Researchers sought to determine whether axi-cel would improve overall survival rates in patients with LBCL.
Study of Early Lymphopheresis for Relapsed/Refractory DLBCL Sheds Light on CAR-T Efficacy
Researchers explored early lymphopheresis for CD19-based chimeric antigen receptor T-cell therapy for relapsed/refractory DLBCL.
CAR T-Cells May Be Safe in Non-Transplant Eligible Patients With Large B-Cell Lymphoma
Researchers sought to determine whether CAR-T therapy would be a viable option for patients with relapsed/refractory large B-cell lymphoma.
Survey Reveals Physician Preferences for Treating Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Researchers sought to determine physician preferences for treating patients with relapsed/refractory diffuse large B-cell lymphoma in the third line setting.
Zamtocabtagene Autoleucel Produces High ORR in Relapsed/Refractory DLBCL
Zamtocabtagene autoleucel produced responses in patients with relapsed/refractory diffuse large B-cell lymphoma in a phase 2 trial.
“Severe4” Predicts Outcomes of CAR T-Cell Therapy in Relapsed/Refractory DLBCL
A prognostic index called “Severe4” can predict outcomes of CAR T-cell therapy in patients with relapsed/refractory DLBCL, a study suggests.
Chronotherapy Study Shows Afternoon Regimens Better for Female Patients With DLBCL
A study evaluating the use of chronotherapy for hematologic cancers identifies how the approach can improve outcomes for some patients.
Outcomes for R-CHOP Worse in Morning for Female Patients With Lymphoma
Progression-free, overall survival significantly lower for female patients receiving chemo mostly in morning.
- Loading...
Loading...
Next post in Lymphoma
Loading... 
Loading...